Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma
Malignant pleural mesothelioma is an aggressive tumor that has a poor prognosis and is resistant to unimodal approaches. Multimodal treatment has provided encouraging results.Phase II, open-label study of the combination of chemotherapy (pemetrexed 500 mg/m²+cisplatin 75 mg/m² IV every 21 days × 3 c...
Saved in:
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Language: | English |
Published: |
2013
|
Online Access: | https://doi.org/10.1186/1471-2407-13-22 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|